Susquehanna International Group
IRMD icon

Susquehanna International Group’s iRadimed IRMD Stock Holding History

Susquehanna International Group’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.71M Buy
+17,800
New +$1.78M ﹤0.01% 6537
2025
Q4 		– Sell
-4,200
Closed -$299K – 12958
2025
Q3 		$299K Hold
4,200
– – ﹤0.01% 10117
2025
Q2 		$251K Buy
+4,200
New +$230K ﹤0.01% 10730

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group's IRMD Position: Q1 2026 in Review

Susquehanna International Group increased its iRadimed (IRMD) stake by 33% in Q1 2026, buying an estimated $699K and bringing the position to 27,981 shares worth $2.69M. The position accounts for ﹤0.01% of the portfolio, ranked #5500.

Susquehanna International Group first reported a position in IRMD in Q1 2023 and has held it in 10 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Susquehanna International Group held 27,981 shares of iRadimed worth $2.69M as of Q1 2026.
  • Susquehanna International Group bought 6,986 iRadimed shares in Q1 2026, an estimated $699K.
  • iRadimed made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5500 holding.
  • Susquehanna International Group first reported a position in iRadimed in Q1 2023 and has held it in 10 quarters since.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.